Investegate |Proteome Sciences Announcements | Proteome Sciences: Director/PDMR Shareholding
Investegate announcements from Proteome Sciences, Director/PDMR Shareholding
Stay updated with breaking news from Proteome Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Proteome Sciences, Director/PDMR Shareholding
Proteome Sciences plc (LON:PRM – Get Rating) insider Martin Diggle acquired 100,000 shares of the firm’s stock in a transaction dated Wednesday, April 5th. The shares were purchased at an average cost of GBX 400 ($4.97) per share, for a total transaction of £400,000 ($496,770.99). Proteome Sciences Stock Up 16.7 % Shares of LON:PRM opened […]
Investegate announcements from Proteome Sciences, Investor Presentation
Investegate announcements from Proteome Sciences, Director/PDMR Shareholding
Proteome Sciences PLC on Tuesday said revenue was up by half, and profit multiplied in 2022. The London-based drug development services provider reported revenue for 2022 of GBP7.8 million, up 52%... | April 4, 2023